Indexiq Etf Trust (AGGP) NPORT-P NYLI Healthy Hearts ETF (Jul 2024 report)

Schedule of Investments ─ NYLI Healthy Hearts ETF (formerly, IQ Healthy Hearts ETF)

July 31, 2024 (unaudited)

	Shares		Value
Common Stocks — 99.9%
Communication Services — 4.8%
Alphabet, Inc., Class A		2,446	$	419,587
Consumer Discretionary — 13.7%
adidas AG		344		86,099
Asics Corp.		3,047		50,122
Basic-Fit NV*(a)		1,727		41,562
Deckers Outdoor Corp.*		55		50,745
Dick’s Sporting Goods, Inc.		185		40,025
Feng TAY Enterprise Co., Ltd.		8,844		37,668
Frasers Group PLC*		3,758		43,226
Garmin Ltd.		335		57,369
Giant Manufacturing Co., Ltd.		6,282		45,294
Moncler SpA		634		37,788
NIKE, Inc., Class B		2,534		189,695
On Holding AG, Class A*		992		41,089
Peloton Interactive, Inc., Class A*		11,588		41,253
Planet Fitness, Inc., Class A*		663		48,863
Pool Corp.		116		43,389
Puma SE		817		40,579
Shimano, Inc.		258		45,835
Technogym SpA		4,176		40,963
Thule Group AB		1,404		38,802
Topgolf Callaway Brands Corp.*		2,696		44,484
Under Armour, Inc., Class A*		5,866		40,886
Vail Resorts, Inc.		224		40,770
VF Corp.(a)		3,176		53,865
Total Consumer Discretionary				1,200,371
Consumer Staples — 2.9%
General Mills, Inc.		1,218		81,777
George Weston Ltd.		297		45,969
Glanbia PLC		2,066		41,337
Kellanova		699		40,647
Loblaw Cos. Ltd.		363		44,736
Total Consumer Staples				254,466
Health Care — 71.4%
Abbott Laboratories		4,136		438,168
Acadia Healthcare Co., Inc.*		612		39,688
Asahi Intecc Co., Ltd.		2,930		46,367
AstraZeneca PLC		2,723		432,580
AtriCure, Inc.*		1,872		40,379
Bangkok Dusit Medical Services PCL		57,475		42,326
Beam Therapeutics, Inc.*		1,771		56,034
Boston Scientific Corp.*		3,169		234,126
Bristol-Myers Squibb Co.		4,385		208,551
Bumrungrad Hospital PCL		6,412		44,252
Centene Corp.*		1,143		87,920
China Traditional Chinese Medicine Holdings Co., Ltd.*		78,196		33,032
Cytokinetics, Inc.*		870		51,339
Edwards Lifesciences Corp.*		1,284		80,956
Elevance Health, Inc.		502		267,079
Eli Lilly & Co.		515		414,199
Encompass Health Corp.		488		45,355
Fresenius SE & Co. KGaA*		1,327		47,659
HCA Healthcare, Inc.		411		149,214
IHH Healthcare Bhd		32,075		43,981
Inari Medical, Inc.*		843		39,250
Johnson & Johnson		2,882		454,924
Koninklijke Philips NV*		1,728		48,766
LivaNova PLC*		691		34,135
Medtronic PLC		2,873		230,759
Merit Medical Systems, Inc.*		520		44,351
Molina Healthcare, Inc.*		134		45,730
Nihon Kohden Corp.		2,764		42,491
Novartis AG		4,093		458,379
Novo Nordisk A/S, Class B		3,132		414,215
Penumbra, Inc.*		223		37,261
Pfizer, Inc.		14,748		450,404
Ramsay Health Care Ltd.		1,346		40,844
Rhythm Pharmaceuticals, Inc.*		1,182		56,984

	Shares		Value
Common Stocks (continued)
Health Care (continued)
Sanofi SA		2,451	$	252,836
Sawai Group Holdings Co., Ltd.		1,084		47,752
Select Medical Holdings Corp.		1,221		48,547
Siemens Healthineers AG		728		39,097
Tenet Healthcare Corp.*		312		46,706
United Therapeutics Corp.*		153		47,933
UnitedHealth Group, Inc.		852		490,888
Zealand Pharma A/S*		453		61,093
Total Health Care				6,236,550
Industrials — 1.5%
Fluidra SA		1,740		38,749
Hayward Holdings, Inc.*		2,911		43,054
Pentair PLC		518		45,516
Total Industrials				127,319
Information Technology — 5.6%
Apple, Inc.		2,199		488,354
Total Common Stocks
(Cost $7,562,611)				8,726,647
Short-Term Investment — 0.4%
Money Market Funds — 0.4%
Dreyfus Government Cash Management Fund, Institutional Shares, 5.22%(b)(c)
(Cost $38,158)		38,158		38,158
Total Investments — 100.3% (Cost $7,600,769)				8,764,805
Other Assets and Liabilities, Net — (0.3)%				(29,683	)
Net Assets — 100%			$	8,735,122

Schedule of Investments ─ NYLI Healthy Hearts ETF (formerly, IQ Healthy Hearts ETF) (continued)

July 31, 2024 (unaudited)

				% of
Country	Value			Net Assets
United States	$	6,202,153			71.0	%
Switzerland		499,467			5.7
United Kingdom		475,805			5.5
Denmark		475,308			5.4
Japan		232,566			2.7
Germany		213,435			2.4
Canada		90,706			1.0
Netherlands		90,328			1.0
Thailand		86,578			1.0
Taiwan		82,963			1.0
Italy		78,751			0.9
Malaysia		43,981			0.5
Ireland		41,337			0.5
Australia		40,844			0.5
Sweden		38,802			0.4
Spain		38,749			0.4
China		33,032			0.4
Total Investments	$	8,764,805			100.3
Other Assets and Liabilities, Net		(29,683	)		(0.3	)
Total Net Assets	$	8,735,122			100.0	%

*	Non-income producing securities.
(a)	All or a portion of the security was on loan. In addition, “Other Assets and Liabilities, Net” may include pending sales that are also on loan. The aggregate market value of securities on loan was $89,600; total market value of collateral held by the Fund was $90,837. Market value of the collateral held includes non-cash U.S. Treasury securities collateral having a value of $52,679.
(b)	Reflects the 1-day yield at July 31, 2024.
(c)	Represents security purchased with cash collateral received for securities on loan.

The following is a summary of the inputs used to value the Fund’s investments as of July 31, 2024. For more information on the valuation techniques, and their aggregation into the levels used in the table below, please refer to the Fund’s most recent semi-annual or annual financial statements.

Description	Level 1		Level 2		Level 3		Total
Asset Valuation Inputs
Investments in Securities:(d)
Common Stocks	$	8,726,647	$	—	$	—	$	8,726,647
Short-Term Investment:
Money Market Funds		38,158		—		—		38,158
Total Investments in Securities	$	8,764,805	$	—	$	—	$	8,764,805

(d) For a complete listing of investments and their industries, see the Schedule of Investments.

For the period ended July 31, 2024, the Fund did not have any transfers into or out of Level 3 within the fair value hierarchy.